A detailed history of Ars Wealth Advisors Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ars Wealth Advisors Group, LLC holds 4,265 shares of AMGN stock, worth $1.12 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,265
Previous 4,313 1.11%
Holding current value
$1.12 Million
Previous $1.35 Million 2.0%
% of portfolio
0.17%
Previous 0.18%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$309.38 - $337.38 $14,850 - $16,194
-48 Reduced 1.11%
4,265 $1.37 Million
Q2 2024

Jul 19, 2024

SELL
$262.75 - $319.31 $14,188 - $17,242
-54 Reduced 1.24%
4,313 $1.35 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $70,443 - $85,034
-262 Reduced 5.66%
4,367 $1.24 Million
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $413,211 - $466,151
-1,616 Reduced 25.88%
4,629 $1.33 Million
Q3 2023

Oct 26, 2023

SELL
$218.65 - $271.46 $217,338 - $269,831
-994 Reduced 13.73%
6,245 $1.68 Million
Q2 2023

Jul 18, 2023

BUY
$214.27 - $253.37 $1.55 Million - $1.83 Million
7,239 New
7,239 $1.61 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $395,076 - $501,992
-1,725 Reduced 7.38%
21,636 $5.68 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $5.24 Million - $5.91 Million
23,361 New
23,361 $5.27 Million
Q3 2022

Nov 08, 2022

SELL
$224.46 - $253.15 $4.78 Million - $5.39 Million
-21,274 Closed
0 $5.27 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $4.58 Million - $5.1 Million
19,861 Added 1405.59%
21,274 $5.18 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $20,172 - $22,316
-92 Reduced 6.11%
1,413 $342,000
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $15,711 - $17,980
-79 Reduced 4.99%
1,505 $339,000
Q3 2021

Oct 26, 2021

BUY
$212.27 - $248.7 $336,235 - $393,940
1,584 New
1,584 $337,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ars Wealth Advisors Group, LLC Portfolio

Follow Ars Wealth Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Wealth Advisors Group, LLC with notifications on news.